Chester County News and Community Website
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX), a biopharmaceutical company specializing in the development of treatments for solid tumors and gynecological cancers, has unveiled its financial outcomes for the …
Context Therapeutics Adjusts Strategy and Reports Financial Update Amidst R&D Pivot Read More
PHILADELPHIA, PA — The biotech company Cabaletta Bio, Inc. (Nasdaq: CABA), known for its pioneering work in autoimmune disease therapeutics, recently announced its financial results and business updates for the …
Cabaletta Bio Forges Ahead: A Strong Year Lays Groundwork for Groundbreaking Autoimmune Disease Therapies Read More
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has unfurled its financial banners for the fourth quarter and full year closing December 31, 2023. Alongside these fiscal results, the company …
Targeting the Heart of the Matter – Mineralys Therapeutics In Pursuit of Transformative Treatments for Hypertension and Adjacent Conditions Read More
PHILADELPHIA, PA — Five Below Inc., the Philadelphia-based retailer much-loved for its wide range of products retailing for $5 or less, recently closed its fiscal year 2023 on a high …
Five Below Inc. Announces Record Sales and Profitability: A Strategic Success Story Amid Global Market Fluctuations Read More
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR), a company dedicated to transforming the lives of patients through the development of innovative therapies, has made notable strides in the …
Larimar Triumphs: Significant Strides Made on the Road to Treating Friedreich’s Ataxia Read More
PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC), a recognized leader in the cell therapy arena, recently announced their full-year financial results up to December 31, 2023, as well as …
Fortifying Ground in Oncology: Century Therapeutics Makes Waves in the Race for Cell Therapy Read More
NEWARK, DE — Artesian Resources Corporation (ARTNA) recently outlined its earnings results for Q4 and the financial year ending December 31, 2023. Despite a decrease in net income by 7.2% …
Artesian Resources Corporation Navigates Market Challenges with Sharp Focus on Investment and Infrastructure Upgrade Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA), a clinical-stage biopharmaceutical company, recently reported an increase in both research and development (R&D) and general administrative expenses for the fourth quarter and …
Savara Inc. Reports Increased Expenses, Anticipates Positive Data from IMPALA-2 Trial Read More
RADNR, PA — Marinus Pharmaceuticals, a leading biopharmaceutical company, reported impressive growth and financial performance for the fourth quarter and also for the year ending December 31, 2023, making a …
Marinus Pharmaceuticals Excels in Q4 Financial Results Aligning with Successful Clinical Trials and Product Performance Read More
HAVERTOWN, PA — AMREP Corporation (NYSE: AXR), a prominent landholder and real estate developer in New Mexico, recently reported a net income of $92,000 for its fiscal third quarter of …
AMREP Corporation Reports Drop in Net Income Despite Revenue Growthn Read More